UTA NURS 5334 QUIZ 2 2026 AcTUAl QUESTIoNS ANd
vERIfIEd ANSWERS (lATEST UpdATE) A+ GRAdE
100% GUARANTEE vERIfIEd By ExpERTS
Infants/children - ANSWER-Use low-potency steroids sparingly; avoid calcineurin
inhibitors <3 yrs.
Older adults - ANSWER-Thinner skin → higher risk of steroid-induced atrophy.
Hormonal therapy (OCPs) - ANSWER-May be used in women for acne.
Isotretinoin, acitretin, and finasteride - ANSWER-Avoid in pregnancy due to teratogenic
effects.
Topical metronidazole and azelaic acid - ANSWER-Safe in pregnancy.
Terbinafine - ANSWER-Avoid in breastfeeding as it accumulates in milk.
Psoriasis treatment - ANSWER-Start with cost-effective topicals (steroids, vitamin D
analogues); escalate to systemic therapy if >5% BSA.
Acne first-line treatments - ANSWER-Benzoyl peroxide and retinoids are inexpensive
and effective.
Isotretinoin - ANSWER-Requires monitoring and registration.
Eczema treatment - ANSWER-Emollients and steroids are first-line; calcineurin
inhibitors for steroid-sparing use.
,Topical steroids monitoring - ANSWER-Monitor for skin atrophy, striae,
hypopigmentation.
Isotretinoin monitoring - ANSWER-Monitor liver function, lipids, pregnancy tests.
Antifungals monitoring - ANSWER-Monitor LFTs for terbinafine and azoles.
Methotrexate monitoring (psoriasis) - ANSWER-Monitor CBC, LFTs, renal function.
Infants/Children drug precautions - ANSWER-Avoid systemic steroids; cautious with
high-potency topicals.
Pregnant women drug precautions - ANSWER-Avoid teratogenic drugs (isotretinoin,
acitretin, finasteride, methoxsalen).
Older adults drug precautions - ANSWER-Higher risk of adverse skin thinning with
steroids.
Transgender patients - ANSWER-Consider hormonal therapies (OCPs, spironolactone)
with attention to interactions.
Sunscreen application - ANSWER-Apply 3 tbsp every 2 hrs, broad spectrum ≥SPF 30.
Steroid use - ANSWER-Apply thin layer, lowest potency, avoid face/perineum unless
directed.
Acne medications - ANSWER-Retinoids may worsen acne before improving; isotretinoin
requires iPledge compliance.
Oral terbinafine for onychomycosis - ANSWER-Must be taken for months.
,Griseofulvin drug-food interaction - ANSWER-With fatty meals ↑ absorption.
Legal prescriptions - ANSWER-Follow state-specific requirements for APRN prescriptive
authority.
Generic names in prescriptions - ANSWER-Use when possible; include strength,
dosage, route, frequency, and duration.
Controlled/teratogenic medications - ANSWER-Ensure they follow federal monitoring
programs.
Epidermis - ANSWER-Protective layer, stratum corneum with lipids/keratin.
Dermis - ANSWER-Connective tissue, sweat glands, sebaceous glands, hair follicles,
vessels.
Ointment - ANSWER-Oil-based, occlusive, best for dry, scaly lesions.
Cream - ANSWER-Water-based, less greasy, for moist/weeping lesions.
Lotion/Solution/Gel/Foam - ANSWER-Useful for hairy areas and widespread application.
Retinoids - ANSWER-Comedolytic, anti-inflammatory agents used in acne treatment.
Benzoyl peroxide - ANSWER-Antibacterial against P. acnes.
Topical antibiotics - ANSWER-Includes clindamycin, erythromycin, dapsone.
Oral antibiotics - ANSWER-Includes doxycycline, minocycline.
Hormonal agents - ANSWER-Includes OCPs for acne treatment.
, Psoriasis topical agents - ANSWER-Includes retinoids (tazarotene), Vitamin D analogs
(calcipotriene, calcitriol), corticosteroids, coal tar, salicylic acid.
Psoriasis systemic agents - ANSWER-Includes methotrexate, cyclosporine, acitretin,
biologics (adalimumab, etanercept, ustekinumab, secukinumab).
Phototherapy for psoriasis - ANSWER-Includes PUVA, narrowband UVB.
Rosacea treatment - ANSWER-Metronidazole (DOC), azelaic acid, doxycycline (oral).
Actinic Keratosis treatment - ANSWER-Includes 5-fluorouracil, imiquimod, cryotherapy.
Actinic Keratosis - ANSWER-5-fluorouracil, imiquimod, cryotherapy.
Eczema - ANSWER-Emollients, steroids, calcineurin inhibitors (tacrolimus,
pimecrolimus).
Verruca (warts) - ANSWER-Salicylic acid, podophyllin, imiquimod, cryotherapy.
Alopecia - ANSWER-Minoxidil (both sexes), finasteride (men only).
Cellulitis/Impetigo - ANSWER-Mupirocin, retapamulin, systemic antibiotics if severe.
Onychomycosis - ANSWER-Oral terbinafine (DOC), topical efinaconazole, tavaborole.
Topical Glucocorticoids Indications - ANSWER-Eczema, psoriasis, allergic/contact
dermatitis.
Topical Glucocorticoids Avoid - ANSWER-Fluorinated steroids on face/perineum.
vERIfIEd ANSWERS (lATEST UpdATE) A+ GRAdE
100% GUARANTEE vERIfIEd By ExpERTS
Infants/children - ANSWER-Use low-potency steroids sparingly; avoid calcineurin
inhibitors <3 yrs.
Older adults - ANSWER-Thinner skin → higher risk of steroid-induced atrophy.
Hormonal therapy (OCPs) - ANSWER-May be used in women for acne.
Isotretinoin, acitretin, and finasteride - ANSWER-Avoid in pregnancy due to teratogenic
effects.
Topical metronidazole and azelaic acid - ANSWER-Safe in pregnancy.
Terbinafine - ANSWER-Avoid in breastfeeding as it accumulates in milk.
Psoriasis treatment - ANSWER-Start with cost-effective topicals (steroids, vitamin D
analogues); escalate to systemic therapy if >5% BSA.
Acne first-line treatments - ANSWER-Benzoyl peroxide and retinoids are inexpensive
and effective.
Isotretinoin - ANSWER-Requires monitoring and registration.
Eczema treatment - ANSWER-Emollients and steroids are first-line; calcineurin
inhibitors for steroid-sparing use.
,Topical steroids monitoring - ANSWER-Monitor for skin atrophy, striae,
hypopigmentation.
Isotretinoin monitoring - ANSWER-Monitor liver function, lipids, pregnancy tests.
Antifungals monitoring - ANSWER-Monitor LFTs for terbinafine and azoles.
Methotrexate monitoring (psoriasis) - ANSWER-Monitor CBC, LFTs, renal function.
Infants/Children drug precautions - ANSWER-Avoid systemic steroids; cautious with
high-potency topicals.
Pregnant women drug precautions - ANSWER-Avoid teratogenic drugs (isotretinoin,
acitretin, finasteride, methoxsalen).
Older adults drug precautions - ANSWER-Higher risk of adverse skin thinning with
steroids.
Transgender patients - ANSWER-Consider hormonal therapies (OCPs, spironolactone)
with attention to interactions.
Sunscreen application - ANSWER-Apply 3 tbsp every 2 hrs, broad spectrum ≥SPF 30.
Steroid use - ANSWER-Apply thin layer, lowest potency, avoid face/perineum unless
directed.
Acne medications - ANSWER-Retinoids may worsen acne before improving; isotretinoin
requires iPledge compliance.
Oral terbinafine for onychomycosis - ANSWER-Must be taken for months.
,Griseofulvin drug-food interaction - ANSWER-With fatty meals ↑ absorption.
Legal prescriptions - ANSWER-Follow state-specific requirements for APRN prescriptive
authority.
Generic names in prescriptions - ANSWER-Use when possible; include strength,
dosage, route, frequency, and duration.
Controlled/teratogenic medications - ANSWER-Ensure they follow federal monitoring
programs.
Epidermis - ANSWER-Protective layer, stratum corneum with lipids/keratin.
Dermis - ANSWER-Connective tissue, sweat glands, sebaceous glands, hair follicles,
vessels.
Ointment - ANSWER-Oil-based, occlusive, best for dry, scaly lesions.
Cream - ANSWER-Water-based, less greasy, for moist/weeping lesions.
Lotion/Solution/Gel/Foam - ANSWER-Useful for hairy areas and widespread application.
Retinoids - ANSWER-Comedolytic, anti-inflammatory agents used in acne treatment.
Benzoyl peroxide - ANSWER-Antibacterial against P. acnes.
Topical antibiotics - ANSWER-Includes clindamycin, erythromycin, dapsone.
Oral antibiotics - ANSWER-Includes doxycycline, minocycline.
Hormonal agents - ANSWER-Includes OCPs for acne treatment.
, Psoriasis topical agents - ANSWER-Includes retinoids (tazarotene), Vitamin D analogs
(calcipotriene, calcitriol), corticosteroids, coal tar, salicylic acid.
Psoriasis systemic agents - ANSWER-Includes methotrexate, cyclosporine, acitretin,
biologics (adalimumab, etanercept, ustekinumab, secukinumab).
Phototherapy for psoriasis - ANSWER-Includes PUVA, narrowband UVB.
Rosacea treatment - ANSWER-Metronidazole (DOC), azelaic acid, doxycycline (oral).
Actinic Keratosis treatment - ANSWER-Includes 5-fluorouracil, imiquimod, cryotherapy.
Actinic Keratosis - ANSWER-5-fluorouracil, imiquimod, cryotherapy.
Eczema - ANSWER-Emollients, steroids, calcineurin inhibitors (tacrolimus,
pimecrolimus).
Verruca (warts) - ANSWER-Salicylic acid, podophyllin, imiquimod, cryotherapy.
Alopecia - ANSWER-Minoxidil (both sexes), finasteride (men only).
Cellulitis/Impetigo - ANSWER-Mupirocin, retapamulin, systemic antibiotics if severe.
Onychomycosis - ANSWER-Oral terbinafine (DOC), topical efinaconazole, tavaborole.
Topical Glucocorticoids Indications - ANSWER-Eczema, psoriasis, allergic/contact
dermatitis.
Topical Glucocorticoids Avoid - ANSWER-Fluorinated steroids on face/perineum.
